
Do you want to shape how rare disease medicines reach patients across Italy? Are you ready to design pricing and access strategies that secure timely reimbursement while sustaining innovation and impact?
As Value Access and Pricing Manager, you will drive the country value, access, and pricing agenda for rare disease therapies. Working closely with Franchises and global partners, you will craft strategies that translate evidence into compelling value narratives, secure national and regional access, and position our medicines for sustainable adoption. Your work will directly influence how and when patients, clinicians, and healthcare systems benefit from breakthrough treatments. In this role, you will connect global guidance to local realities, anticipate regulatory shifts, and lead negotiations and submissions that matter.
You will be a catalyst for collaboration across Regulatory, Medical Affairs, Government Affairs, Commercial, and regional teams—ensuring decisions are grounded in data, aligned to brand goals, and ready for the evolving EU HTA and JCA landscape.
We carefully consider all applications, including those from candidates eligible under Italian Protected Categories legislation (Art. 1 and Art. 18, L. 68/99).
Join a team where bold ideas and practical execution come together to move life-changing medicines to the people who need them most. You will work with the entrepreneurial energy of a leading biotech backed by the scale and investment of a global biopharma, in a culture that values kindness alongside ambition. We bring unexpected teams into the same room to challenge assumptions, connect deeply to patient lived experiences, and turn complex science and evidence into access that matters. In-person collaboration several days a week fuels pace and clarity, while flexibility respects individual needs.
Here, your expertise in access and pricing is amplified by supportive leaders, tailored development, and the chance to shape what comes next for rare disease care.
Call to Action: If you’re ready to lead pricing and access decisions that change the trajectory of rare disease care in Italy, step into this role and create impact that endures.
Contract Level: A1 or A3, depending on the candidate’s experience in the role.
CBA: Chemical-Pharmaceutical
Full-time
Permanent
18-nov-2026
02-dic-2026
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy